Brookline Capital Markets
Affiliates

Track Record

Transactions

The team has completed over 300 transactions and engagements for its clients — valued at over $35 billion — as Bookrunner, Co-Manager, Lead Placement Agent, Co-Placement Agent or Advisor.

Featured Transactions

  1. April 2025Alcyone TherapeuticsBrookline served as Exclusive Placement Agent for the Series F Convertible Preferred stock offering.
  2. September 2025Sale to BiogenBiogen acquired Alcyone Therapeutics in 2025. Brookline served as Alcyone's financial advisor.
  3. July 2026Neela TherapeuticsNeela Therapeutics was spun out of the acquisition and Brookline served as the Exclusive Placement Agent for a Convertible Note in 2026.

Selected Client Transactions

Transaction results

  • Carmell

    $3,000,000

    PIPEExclusive Placement Agent

  • Anthropic

    Undisclosed

    Secondary SaleIntroducing Agent

  • Rallybio

    $6,600,000

    PIPEFinancial Advisor

  • Aquestive Therapeutics

    Completed EngagementCapital Markets Advisor

  • Adial Pharmaceuticals

    Capital Markets AdvisorCompleted Engagement

  • Cyclacel Pharmaceuticals

    $8,000,000

    PIPEFinancial Advisor

  • Aquestive Therapeutics

    $75,000,000

    Follow-OnFinancial Advisor

  • CervoMed

    $50,000,000

    PIPEFinancial Advisor

  • DT Cloud

    $69,000,000

    IPOSole Bookrunner

  • Immunic

    $80,000,000

    PIPEFinancial Advisor

  • Scientific Industries

    $7,000,000

    PIPEExclusive Placement Agent

  • Wave Aerospace

    $1,100,000

    Series AExclusive Placement Agent

  • Imunon

    Completed EngagementCapital Markets Advisor

  • CoreWeave

    $6,750,000

    Secondary SaleIntroducing Agent

  • iBio

    $4,500,000

    Follow-OnCo-Placement Agent

  • Iron Horse Acquisitions Corp.

    $69,000,000

    IPOCo-Manager

  • AI Transportation Acquisition Corp

    $60,000,000

    IPOCo-Manager

  • SAB Biotherapeutics

    $67,100,000

    PIPEFinancial Advisor

  • Quetta Acquisition Corp.

    $69,000,000

    IPOCo-Manager

  • Circulogene

    $12,670,000

    Secured NoteSole Placement Agent

  • Hepion Pharmaceuticals

    Completed EngagementCapital Markets Advisor

  • Lung Therapeutics

    $18,500,000

    PIPECo-Placement Agent

  • Calidi Biotherapeutics

    $25,000,000

    Series BPlacement Agent

  • Calidi Biotherapeutics / FirstLight Acquisition Group

    $335,000,000

    MergerFinancial Advisor